Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Neuroone Medical Technologies (NMTC) Other Gross PP&E Adjustments (2018 - 2026)

Neuroone Medical Technologies filings provide 7 years of Other Gross PP&E Adjustments readings, the most recent being -$489089.0 for Q1 2026.

  • On a quarterly basis, Other Gross PP&E Adjustments fell 56.93% to -$489089.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$489089.0, a 56.93% decrease, with the full-year FY2025 number at -$385295.0, down 198.76% from a year prior.
  • Other Gross PP&E Adjustments hit -$489089.0 in Q1 2026 for Neuroone Medical Technologies, down from -$361495.0 in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $1.9 billion in Q3 2022 to a low of -$489089.0 in Q1 2026.
  • Median Other Gross PP&E Adjustments over the past 5 years was -$169059.0 (2023), compared with a mean of $111.4 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: surged 443514.98% in 2022 and later crashed 198.76% in 2025.
  • Neuroone Medical Technologies' Other Gross PP&E Adjustments stood at $297454.0 in 2022, then crashed by 147.13% to -$140198.0 in 2023, then skyrocketed by 546.74% to $626326.0 in 2024, then tumbled by 157.72% to -$361495.0 in 2025, then crashed by 35.3% to -$489089.0 in 2026.
  • The last three reported values for Other Gross PP&E Adjustments were -$489089.0 (Q1 2026), -$361495.0 (Q4 2025), and -$385295.0 (Q3 2025) per Business Quant data.